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INHIBITION OF THE ACTIVITIES OF GLUTAMIC, MALIC AND LACTIC
DEHYDROGENASES BY GLUCOCORTICOIDS IN NORMAL
AND PSORIATIC EPIDERMIS*
KEN HAS11IMOTO, M.D., MAURAY J. TYE, M.D. AND WALTER F. LEVER, MI).
Several reports indicate that the steroid sex
hormones, namely testosterone, diethyistilbestrol
and progesterone, inhibit glutamic dehydrogenase
(GDH) (1) and reduce diphosphopyridine nucleo-
tide-cytochrome c reductase (2, 3). Furthermore,
adrenal glucocorticoids have been found to sup-
press glucose oxidation and oxygen consumption
in vitro and in vivo (4). A study was therefore
undertaken to determine, by means of histo-
chemical technics, the effects of glucocorticoids
on several dehydrogenases in human skin which
are associated with the tricarboxylic acid cycle.
In addition to normal skin, psoriatic skin was
used for these studies because of its known
response to the topical application of glucocorti-
coids. In this paper we wish to report that several
glucocorticoids have been found to inhibit the
lactic (LDH), glutamic (GDH), and malic
(MDII) dehydrogenase activities of both normal
human and psoriatic skin.
MATERIALS AND METHODS
Three patients with psoriasis were studied. The
first two patients showed the acute stage of the
disease, while the third patient showed subacute
to chronic lesions. A total of twenty-five biopsy
specimens were taken from these three patients
for Experiments 1 through 5. In each patient the
biopsy specimens were taken also from similar
lesions and, whenever possible, from various sites
of one large plaque. Each time a biopsy specimen
was taken from unaffected skin at a corresponding
opposite site. All biopsy removals were performed
under local anesthesia with a 6 mm punch.
The biopsy specimens were frozen immediately
after excision and sections 35 thick were cut with
a freezing microtome. Immediately thereafter,
the sections were incubated in the substrate media
described by Nachlas et at (5) for the demonstra-
tion of GDH, MDH and LDH. The added sub-
* From the Department of Dermatology, Tufts
University School of Medicine, and the Derma-
tology Research Laboratories of the Boston
Dispensary, Boston, Massachusetts.
This investigation was supported by Public
Health Service Grant GM-10299 from the Division
of General Medical Sciences and by Graduate
Training Grant 2A-5220 from the National In-
stitute of Arthritis and Metabolic Diseases.
Received for publication June 24, 1963.
61
strates were sodium glutamate, sodium malate
and lithium lactate for demonstration of the
GDH, MDH and L1)H activities, respectively.
The period of incubation was 45 minutes at 37° C.
After incubation, the sections were fixed in a 10%
formol calcium solution for one hour and then
either were mounted in glycerine jelly or were de-
hydrated through alcohol for embedding in
Canada balsam. For the purpose of control, sec-
tions were incubated also in media without sub-
strate.
The following fluorinated glucocorticoid solu-
tions or suspensions were used: (1) 0.4%
dexamethasone 21-phosphate solution (Decadron
phosphate for injection, Merck, Sharp and
Dohme), (2) 4% methylprednisolone sodium succi-
nate solution (Solu-Medrol, Upjohn), (3) 4% tn-
amcinolone diacetate suspension (Aristocort
suspension, Lederle Laboratories Division), (4)
1% triamcinolone acetonide suspension (Kenalog
parenteral, E. R. Squibb & Sons), and (5) fluocino-
lone acetonide (furnished by Syntex Laboratories)
suspended at 2% concentration in normal saline.
Other steroids tested were diethylstilbestrol
(Diethylstilbestrol in oil, Abbott), progesterone(Lipo-Lutin, Parke, Davis & Co.) and desoxy-
corticosterone acetate (DOCA acetate, Organon
Inc.).
For controls, skin sections were incubated in
the sterile vehicle for dexamethasone phosphate
(vehicle for injectable Decadron phosphate, espe-
cially supplied by Merck, Sharp and Dohme Re-
search Laboratories). Also, for control of the in
vivo experiments hydrophilic ointment as well as
hydrophilie ointment containing either 2% sulfur
or 5% crude coal tar were applied to psoriatic
lesions.
EXPERIMENTS AND RESULTS
The following experiments were performed:
1. Comparison of Dehydrogenase Activities in
Normal and Psoriatic Epidermis. Biopsy sections
of psoriatic lesions and of normal skin from cor-
responding areas of the same patient were incu-
bated in substrate media for the demonstration
of GDH, MDII, and LDH. All sections from
psoriatic lesions reacted more intensely than those
of normal skin for all three enzymes (Fig. la).
Acute psoriatic lesions showed a stronger inten-
sity of staining than less acute or treated lesions.
2. Pre-incubation of Normal and Untreated
Psoriatic Skin with Glucosteroids, Progesterone
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FIG. la. Psoriasis (Case 1). LDS stain. There is intense enzymatic activity in all layers of the epi-
dermis. The enzymatic activity is located in the cytoplasm rather than in the nuclei. (X 213)
FIG. lb. Psorjasis (Case 1). LDS stain after incubation in a 1% triaminolone acetonide solution. On
the whole, there is a marked decrease in enzymatic activity. However, several cells in the epidermis re-
main as strongly reactive as before. (X 213)
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and Diet hylstilbe.sterol. Sections of both un-
treated psoriatic lesions and normal skin were
incubated at 37° C. for 15 minutes in the five
glucocorticoid solutions or suspensions listed
under Methods. They were briefly rinsed with
distilled water and incubated for 15 minutes in
the substrate media for demonstration of CDII,
MDII, and LDII activities. Pre-incubation in the
glucocorticoid solutions or suspensions caused
suppression of all three dehydrogenases (Fig.
ib). Although the normal as well as the psoriatic
epidermis showed a decrease in CDII, MDII and
LDH activities, the amount of suppression was
less in the normal than in the psoriatie epidermis,
since the initial staining reaction was not as
strong as in the psoriatie lesions. No detectable
differences were observed between the various
types of glueoeortieoids in the concentrations
Fjo. 2a. Psoriasis (Case 3). GDS stain. Strong enzymatic activity is evident in the epidermis. (X 200)
Fm. 2b. Psoriasis (Case 3). GDS stain 15 minutes after an intradermal injection of 2% fluocinolone
acetonide (Synalar). There is a considerable decrease in enzymatic activity. (X 200)
:1
.:.
 
e
l 
7 
tt:
 4: 
64 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
used. However, a greater suppression of enzyme
activity was obtained by glucocorticoids in solu-
tion than by glucocorticoids in suspension. While
all enzyme activities tested were suppressed,
the suppression of LDH within the epidermis was
uneven since some areas within the epidermis
reacted almost as strongly after incubation with
glucocorticosteroids as they had before incuba-
tion (Fig. ib).
Incubation with DOCA did not appreciably
affect any of the enzymes tested. On the other
hand, progesterone and diethylstilbestrol in-
hibited the various enzyme activities slightly.
3. Pre-injection of Glucocorticoids into Psoriatic
and Normal Skin. A 0.4% injectable dexametha-
sone phosphate solution, a 2% fluocinolone aceto-
nide suspension or a 1 % triamcinolone acetonide
suspension was injected intradermally into nor-
mal skin and into psoriatic lesions, either 15
minutes or 1 hour prior to removal of tissue. The
amount of inhibition obtained varied from one
lesion to another even with the same glucocorti-
coid preparation, although an interval of one
hour between the intradermal injection and per-
formance of the biopsy removal resulted in a more
consistent suppression than an interval of only 15
minutes. The aqueous solutions, on the average,
showed a greater effect than suspensions (Figs.
2a, 2b).
4. Duration of the Inhibitory Effect of Topically
Applied Glucocorticoids. A cream containing
0.025% fluocinolone acetonide was massaged into
psoriatic lesions and into normal skin. Biopsy
specimens taken immediately after application
showed no inhibition of enzyme activities, those
taken after 5 to 10 minutes showed a slight degree
of inhibition, and those taken within 1 to 2 hours
showed a great deal of inhibition of enzyme ac-
tivity, both in psoriatic and in normal epidermis
(Figs. 2a, 3). A fair degree of inhibition usually
was still evident in biopsies taken 2 to 3 hours
later. However, biopsies taken 3 to 4 hours later
no longer showed inhibition of enzyme activity.
5. Controls. For the purpose of controls, sec-
tions of skin were incubated for 15 minutes in the
sterile vehicle for injectable dexamethasone phos-
phate. Also, plain hydrophilic ointment, 2%
sulfur in hydrophilic ointment or 5% crude coal
tar in hydrophilic ointment was massaged into
psoriatic lesions in place of the 0.025% fluocino-
lone acetonide cream two hours prior to biopsy
excision. No significant inhibition of enzyme
activities was observed. Also, incubation of skin
sections in substrate-free media (not containing
glutamate, malate and lactate) revealed no
enzymatic activity in the epidermal cells, except
in the upper stratum malpighii and in the kera-
togenous zone of the hair, corresponding to the
Fin. 3. Psoriasis (Case 3). GDS stain one hour after the topical application of 0.025% fluocinolone
acetonide cream. There is a marked decrease in enzymatic activity in the epidermis as compared with
the untreated lesion in Fig. 2a. (X 200)
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areas where sulfhydryl groups are abundant.
This reaction results from a Don-specific reduction
of tctrazolium salts by sulfhydryl groups (6).
In addition to the studies on the skin, rat liver
and kidney were used to assay the inhibitory
effect of glucocorticoids on GDH, MDH and
LDH since these organs contain greater amounts
of these enzymes than the epidermis. A pro-
nounced inhibitory effect was evident in histo-
logic sections of liver and kidney after 15 minutes
of pre-incubation in a dexamethasone solution,
while the vehicle without the glucocorticoid
caused no inhibition.
Sections of skin were immersed in distilled
water for 15 minutes prior to their incubation in
the reaction media. This treatment did not lower
the enzymatic activity, indicating that the ob-
served differences in enzyme activities were not
the result of extraction during rinsing.
DISCUSSION
All of the glucocorticoids tested as well as
progesterone and diethylstilbcstrol were found to
have an inhibitory effect on cpidermal dehydro-
genascs, such as glutamic, malic, and lactic
dehydrogenase, both in vivo and in vitro.
The intensity of activity of the dehydrogcnases
was proportional to the degree of acanthosis of
the epidermis. This suggests that the energy re-
quired for the increased production of cpidcrmal
cells is supplied by the energy-yielding oxidation
systems involving the tricarboxylic acid cycle. It
is interesting that the inhibitory effect of the
glucocorticoids on the dehydrogcnases lasted only
3 hours, suggesting the clinical importance of
frequent applications of corticosteroid prepara-
tions.
Biochemical Data
It was found that glutamic dchydrogcnasc
(GDH) unfolds or dissociates into four subunits of
equal size on dilution (7), on exposure to certain
inhibitors, or on exposure to high concentrations
of either substrate, or reduced diphosphopyridine
nuclcotidc (8, 9). Among the inhibitors of GDH,
Yielding and Tomkins (1) listed several sex
steroid hormones, such as progesterone, diethyl-
stilbcstrol (in the presence of DPNH) and their
analogs. They stated that DOCA showed no
inhibitory effect on GDH. These results are in
agreement with our histochemical findings. The
sex steroids appear to alter CDII by interfering
with the non-covalent (probably hydrophobic)
bonding among the subunits (1).
It can be assumed that the glucocorticoids
inhibit LDH in the same way as they inhibit
GDH (10). LDH, like GDH, is composed of four
identical sub-units which appear to be held to-
gether by non-covalent or hydrophobic bonds
(10, 11).
SUMMARY
1. In vitro and in vivo histochcmical tests were
carried out in order to determine the inhibitory
effects of several glucocorticoids, of desoxycorti-
costeronc acetate and of the gonadal steroids on
dehydrogcnascs present in the epidermis, namely
malic, lactic and glutamic dehydrogenascs.
2. All glucocorticoids tested inhibited the ac-
tivity of these dchydrogenascs in vivo and in
vitro. On application of a glucocorticosteroid-con-
taming cream to the skin the inhibitory effect
became apparent after 5 to 10 minutes, was most
pronounced after 1 to 2 hours, and had disap-
peared after 3 to 4 hours.
3. Gonadal steroid hormones also inhibited the
enzymatic activities, but to a lesser degree. DOCA
exerted no detectable inhibition of these enzymes.
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